The cost‐effectiveness of pharmacotherapy and lifestyle intervention in the treatment of obesity

BACKGROUND: The Food and Drug Administration has approved several pharmacotherapies for the treatment of obesity. This study assesses the cost‐effectiveness of six pharmacotherapies and lifestyle intervention for people with mild obesity (body mass indices [BMIs] 30 to 35). METHODS: A microsimulatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Minyi, Lauren, Brianna N., Zhan, Tiannan, Choi, Jin, Klebanoff, Matthew, Abu Dayyeh, Barham, Taveras, Elsie M., Corey, Kathleen, Kaplan, Lee, Hur, Chin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156872/
https://www.ncbi.nlm.nih.gov/pubmed/32313674
http://dx.doi.org/10.1002/osp4.390

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156872/
https://www.ncbi.nlm.nih.gov/pubmed/32313674
http://dx.doi.org/10.1002/osp4.390

Ejemplares similares